A Phase 1b, Multicentre, Open Label, Study of the Efficacy, Safety and Tolerability of R131 Vaginal Ointment in Women with Cytological Abnormalities of the Uterine Cervix
Phase of Trial: Phase I/II
Latest Information Update: 02 Jul 2019
Price : $35 *
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- Sponsors Douglas Pharmaceuticals
- 14 Jun 2019 Recruitment completion is expected on 15 Jul 2019.
- 14 Jun 2019 Planned End Date changed from 7 Dec 2019 to 2 Dec 2019.
- 14 Jun 2019 Status changed from not yet recruiting to recruiting.